Known hypersensitivity to any of the components of the product or to other dihydropyridines or β-blockers. Pregnancy. Unstable angina pectoris. Degree II and III AV block. Patients with unstable uncompensated heart failure (pulmonary edema, hypoperfusion or hypotension), and patients with continuous or intermittent inotropic therapy with β-receptor agonism. Symptomatic bradycardia or hypotension. Sick sinus syndrome. Cardiogenic shock. Severe peripheral vascular disease with threat of gangrene. Felodipine/Metoprolol succinate (LOGIMAX) must not be given to patients with suspected acute myocardial infarction with a heart rate of <45 beats/minute, P Q interval >0.24 seconds or systolic blood pressure <100 mmHg.
Sign Out
